1. Home
  2. XRAY vs IMNM Comparison

XRAY vs IMNM Comparison

Compare XRAY & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$10.47

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.51

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRAY
IMNM
Founded
1899
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
XRAY
IMNM
Price
$10.47
$18.51
Analyst Decision
Hold
Strong Buy
Analyst Count
14
10
Target Price
$14.58
$32.80
AVG Volume (30 Days)
5.8M
1.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
5.58%
N/A
EPS Growth
33.04
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.06
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$7.96
52 Week High
$17.09
$27.65

Technical Indicators

Market Signals
Indicator
XRAY
IMNM
Relative Strength Index (RSI) 50.32 34.39
Support Level $9.63 $16.81
Resistance Level $10.65 $19.16
Average True Range (ATR) 0.47 1.23
MACD 0.10 -0.32
Stochastic Oscillator 83.06 8.72

Price Performance

Historical Comparison
XRAY
IMNM

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: